SCHEMBL6533567

SCHEMBL6533567

CCNC(=O)N1CCC(c2nc(C(=O)N3CCCC4CCCC=C43)cs2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.36
PPARG P37231 1/20 0.35
BAZ2A Q9UIF9 1/20 0.34
SPR P35270 2/20 0.34
BRD4 O60885 1/20 0.34
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33
SLC40A1 Q9NP59 1/20 0.33
TRPC3 Q13507 2/20 0.33
TRPC6 Q9Y210 2/20 0.33
PIM1 P11309 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
GAA P10253 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CNR1 P21554 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15121653 0.88 FAAH (0.35) FAAHPPARGSLC40A1TRPC3TRPC6
SCHEMBL15121790 0.88 PPARG (0.34) PPARGBAZ2ASPRTRPC3TRPC6
SCHEMBL15121846 0.86 PPARG (0.32) PPARGPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL6526733 0.86 BAZ2A (0.37) FAAHPPARGBAZ2ASPRPIK3CD
SCHEMBL3455430 0.85 TRPC3 (0.34) FAAHPPARGSPRTRPC3TRPC6
SCHEMBL6521630 0.85 PPARG (0.35) PPARGBAZ2ASPRTRPC3TRPC6
SCHEMBL15121628 0.84 L3MBTL1 (0.35) PPARGBAZ2ASPRTRPC3TRPC6
SCHEMBL6526994 0.84 PDE4B (0.39) PPARGSPRPIM1PIM3PIM2
SCHEMBL1044752 0.84 SMYD3 (0.35) PPARGBAZ2ASPRPIM1PIM3
SCHEMBL15121672 0.84 PDE4B (0.35) PPARGSPRTRPC3TRPC6PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110060007-A1 Novel NIP Thiazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydroge-Nase-1 Merck Patent Gesellschaft Mit Beschrankter Haftling (DE) 2011-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110060007-A1 Novel NIP Thiazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydroge-Nase-1 HSD11B1, HSD17B1, HSD11B2 FAAH 2492/4885PPARG 744/4885BAZ2A 4597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.